BioProduction by SEKISUI’s Kirsty Bellchambers and Aurore Laborie-Thompson share insights into what drug developers need to know about transferring their biologics processes to a CDMO partner.
SEKISUI
Tech transfer for microbial therapeutic protein manufacturing
BioProduction by SEKISUI’s Kirsty Bellchambers and Aurore Laborie-Thompson share insights into what drug developers need to know about transferring their biologics processes to a CDMO partner.
Published:
|
4 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.